CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
Active, not recruiting · NCT05215470 · Registry updated 2024-07-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, kidney cancer, kidney disorder, neoplasm, urinary system disorder | Active, not recruiting | Phase 2 | 2024-07-03 | NCT05215470 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | 33 |
| Hospital das Clínicas de Ribeirão Preto | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital das Clínicas da Faculdade de Medicina de Ribeirao Preto - USP | Ribeirão Preto | Brazil | 1 |